StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Tolazolin

Tolazoline

HCID 5504
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
59-98-3
Standard-SMILES
c1ccc(CC2=NCCN2)cc1
InChIKey
JIVZKJJQOZQXQB-UHFFFAOYSA-N
Summenformel
C10H12N2
Durchschnittliche Molmasse
160,22 g/mol
Monoisotopische Masse
160,10004839

Überblick

Tolazoline is a member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group. It has a role as a vasodilator agent, an antihypertensive agent and an alpha-adrenergic antagonist.

Namen und Bezeichner

Bevorzugter Name
Tolazoline
IUPAC
2-benzyl-4,5-dihydro-1H-imidazole
Lokaler Name
Tolazolin
Englischer Name
Tolazoline
Summenformel
C10H12N2
Molmasse
160.22

Namen und Synonyme

tolazoline59-98-32-Benzylimidazoline2-Benzyl-4,5-dihydro-1H-imidazoleBenzazoline2-Benzyl-2-imidazoline2-Benzyl-4,5-imidazolineTolazolinaTolazineTolazolinum4,5-Dihydro-2-(phenylmethyl)-1H-imidazole1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-
Weitere Namen anzeigen
PriscolineVasodilVasimidArtonilKasimidLambrilPriscolBenzolinciba3259
CHH9H12AQ3NSC-35110BenzalolinDTXSID3023683CHEBI:28502RefChem:56141DTXCID103683C04AB02

Datenbank-Bezeichner

CAS
59-98-3
PubChem CID
5504
DTXSID
DTXSID3023683
ChEMBL
CHEMBL770
ChEBI
CHEBI:28502
UNII
CHH9H12AQ3

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
2,6
Polarare Oberfläche (TPSA)
24,4 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
1
Frei drehbare Bindungen
2
Schwere Atome
12
Formalladung
0
Komplexität
169

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
LogP1.5
Solubility1.36e+00 g/L
Melting Point174 °C
Physical DescriptionSolid
Dissociation Constants10.3
Collision Cross Section133.41 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
66 · 66-69 °C(lit.)
Siedepunkt
188 °C/20mmHg · 188°C/20mmHg(lit.)
Dichte
1.0849 · 1.0849 (rough estimate)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302+H312+H332 (44.1%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 68 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationTolazoline: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Sicherheitsdaten

wgk
3
hs_code
2933299090
RTECS-Nr.
NJ1925000
risk_code
20/21/22-36/37/38
Toxizität
cyt-ham:lng 62,500 mg/L GMCRDC 27,95,81
hazard_code
Xn
safety_code
26-28-36/37/39-45
Speicherklasse

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 5 Einträge

C - Cardiovascular system

M - Musculo-skeletal system

QC - Cardiovascular system

QV - Various

QM - Musculo-skeletal system

PharmacodynamicsTolazoline is a pulmonary vasodilator indicated used to decrease pulmonary vascular resistance (PVR) in persistent pulmonary hypertension of the newborn (PPHN).
Mechanism of Action · 1 Eintrag

Vasodilation by means of a direct effect on peripheral vascular smooth muscle and indirect effects produced, in part, by release of endogenous histamine; tolazoline has moderate alpha-adrenergic blocking activity and has histamine agonist activity. Tolazoline usually reduces pulmonary arterial pressure and vascular resistance.

MeSH Pharmacological Classification · 3 Einträge

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs used to cause dilation of the blood vessels.

Cellular LocationsMembrane

Anwendungen

VerwendenTolazoline is used for treating stable forms of pulmonary hypertension in newborns, and in cases where systemic arterial oxygenation cannot be achieved in the usual manner under careful observation of professionals.

Vor- und nachgelagerte Produkte

Zugehörige Reaktionen

5
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 543302
HRID 543302als Edukt
Reaktionsgleichung von HRID 979728
HRID 979728als Edukt
Reaktionsgleichung von HRID 2152380
HRID 2152380als Edukt
Reaktionsgleichung von HRID 2231343
HRID 2231343als Edukt
Reaktionsgleichung von HRID 2309687
HRID 2309687als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
200-448-9
Nikkaji
J4.796A
Brechungsindex
1.6392 · 1.6392 (estimate)
storage temp.
2 · 2-8°C
Löslichkeit
alcohol: freely soluble
pka
10.3 · pKa 10.3(H2O t undefined I = 0.1) (Uncertain)
Aggregatzustand
Solid
Farbe
Crystals from pet ether
Merck
14 · 14,9506
InChI
1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12)
InChIKey
JIVZKJJQOZQXQB-UHFFFAOYSA-N
SMILES
C1CN=C(Cc2ccccc2)N1
CAS Datenbank
59 · 59-98-3(CAS DataBase Reference)
NIST chemische Informationen
1 H-Imidazole, · 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-(59-98-3)
EPA chemische Informationen
1 H-Imidazole, · 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)- (59-98-3)
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3

Vorgelagerte Rohstoffe

PhenylacetonitrilEthanol1,2-Diaminoethan

Ergänzende Hinweise

DefinitionChEBI: A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.